Intracranial tumours after external fractionated radiotherapy for pituitary adenomas in northern Sweden

Acta Oncologica

Volumn 49, Issue 8, 2010, Pages 1276-1282

  Norberg, Lars ^a   Johansson, Robert ^a   Rasmuson, Torgny ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACTH SECRETING ADENOMA; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER RISK; CHILD; EXTERNAL FRACTIONATED RADIOTHERAPY; FEMALE; FOLLOW UP; GLIOMA; GROWTH HORMONE SECRETING ADENOMA; HUMAN; HYPOPHYSIS ADENOMA; INTRACRANIAL TUMOR; MAJOR CLINICAL STUDY; MALE; MENINGIOMA; POSTOPERATIVE CARE; PRESCHOOL CHILD; PRIMARY TUMOR; PRIORITY JOURNAL; RADIATION DOSE; RETROSPECTIVE STUDY; SCHOOL CHILD; SWEDEN; TREATMENT DURATION;

ADENOMA; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; CHILD; DOSE FRACTIONATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS, RADIATION-INDUCED; NEOPLASMS, SECOND PRIMARY; PITUITARY NEOPLASMS; RADIOTHERAPY; REGISTRIES; RETROSPECTIVE STUDIES; SWEDEN; YOUNG ADULT;

EID: 77958190197     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/02841861003782025     Document Type: Article

References (25)

1. Modan B, Baidatz D, Mart H, Steinitz R, Levin SG. Radiation-induced head and neck tumours. Lancet 1974;1:277-9.
2. Wrensch M, Minn Y, Chew T, Bondy M, Berger MS. Epidemiology of primary brain tumors: Current concepts and review of the literature. Neuro Oncol 2002;4:278-99.
3. Dekkers OM, Pereira AM, Romijn JA. Treatment and followup of clinically non-functioning pituitary macroadenomas. J Clin Endocrinol Metab 2008;93:3717-26.
4. Bondy ML, Scheurer ME, Malmer B, Barnholtz-Sloan JS, Davis FG, Il'yasova D, et al. Brain tumor epidemiology: Consensus from the Brain Tumor Epidemiology Consortium. Cancer 2008;113(7 Suppl): 1953-68.
5. Goldberg MB, Sheline GE, Malamud N. Malignant intracranial neoplasms following radiation therapy for acromegaly. Radiology 1963;80:465-70.
6. Shore RE, Albert RE, Pasternack BS. Follow-up study of patients treated by X-ray epilation for Tinea capitis; resurvey of post-treatment illness and mortality experience. Arch Environ Health 1976;31:21-8.
7. Ron E, Modan B, Boice JD Jr, Alfandary E, Stovall M, Chetrit A, et al. Tumors of the brain and nervous system after radiotherapy in childhood. N Engl J Med 1988;319:1033-9.
8. Umansky F, Shoshan Y, Rosenthal G, Fraifeld S, Spektor S. Radiation-induced meningioma. Neurosurg Focus 2008;24: E7.
9. The National Board of Health and Welfare in Sweden. Cancer incidence in Sweden 2007. 2007; Official statistics of Sweden.
10. Ezzat S, Asa SL, Couldwell WT, Barr CE, Dodge WE, Vance ML, et al. The prevalence of pituitary adenomas: A systematic review. Cancer 2004;101:613-9.
11. Daly AF, Rixhon M, Adam C, Dempegioti A, Tichomirowa MA, Beckers A. High prevalence of pituitary adenomas: A cross-sectional study in the province of Liège, Belgium. J Clin Endocrinol Metab 2006;91:4769-75.
12. Woollons AC, Hunn MK, Rajapakse YR, Toomath R, Hamilton DA, Conaglen JV, et al. Non-functioning pituitary adenomas: Indications for postoperative radiotherapy. Clin Endocrinol (Oxf) 2000;53:713-7.
13. Park P, Chandler WF, Barkan AL, Orrego JJ, Cowan JA, Griffith KA, et al. The role of radiation therapy after surgical resection of nonfunctional pituitary macroadenomas. Neurosurgery 2004;55:100-7.
14. McCord MW, Buatti JM, Fennell EM, Mendenhall WM, Marcus RB Jr, Rhoton AL, et al. Radiotherapy for pituitary adenoma: Long-term outcome and sequelae. Int J Radiat Oncol Biol Phys 1997;39:437-44.
15. Nilsson B, Gustavsson-Kadaka E, Bengtsson B-Å, Jonsson B. Pituitary adenomas in Sweden between 1958 and 1991: Incidence, survival, and mortality. J Clin Endocrinol Metab 2000;85:1420-5.
16. Brada M, Ashley S, Ford D, Traish D, Burchell L, Rajan B. Cerebrovascular mortality in patients with pituitary adenoma. Clin Endocrinol (Oxf) 2002;57:713-7.
17. Brada M, Ford D, Ashley S, Bliss JM, Crowley S, Mason M, et al. Risk of second brain tumour after conservative surgery and radiotherapy for pituitary adenoma. BMJ 1992;304:1343-6.
18. Tsang RW, Laperriere NJ, Simpson WJ, Brierley J, Panzarella T, Smyth HS. Glioma arising after radiation therapy for pituitary adenoma. A report of four patients and estimation of risk. Cancer 1993;72:2227-33.
19. Bliss P, Kerr GR, Gregor A. Incidence of second brain tumours after pituitary irradiation in Edinburgh 1962-1990. Clin Oncol (R Coll Radiol) 1994;6:361-3.
20. Erfurth EM, Bulow B, Mikoczy Z, Svahn-Tapper G, Hagmar L. Is there an increase in second brain tumours after surgery and irradiation for a pituitary tumour? Clin Endocrinol (Oxf) 2001;55:613-6.
21. Minniti G, Traish D, Ashley S, Gonsalves A, Brada M. Risk of second brain tumor after conservative surgery and radiotherapy for pituitary adenoma: Update after an additional 10 years. J Clin Endocrinol Metab 2005;90:800-4.
22. Norberg L, Johansson R, Rasmuson T. Pituitary adenomas in northern Sweden: A study on therapy choices and the risk of second primary tumours. Clin Endocrinol (Oxf) 2008;68:780-5.
23. Vernooij MW, Ikram MA, Tanghe HL, Vincent AJ, Hofman A, Krestin GP, et al. Incidental findings on brain MRI in the general population. N Engl J Med 2007;357:1821-8.
24. Barlow L, Westergren K, Holmberg L, Talbäck M. The completeness of the Swedish Cancer Register-a sample survey for year 1998. Acta Oncol 2009;48:27-33.
25. Neglia JP, Robison LL, Stovall M, Liu Y, Packer RJ, Hammond S, et al. New primary neoplasms of the central nervous system in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. J Natl Cancer Inst 2006;98:1528-37.